childhood absence epilepsy (CAE) and juvenile absence epilepsy (JAE). Although classified as two different syndromes, overlap exists and the clinical separation may be challenging (Guerrini, 2006; Myers & Fecske, 2016; Panayiotopoulos, 2001; Tenney & Glauser, 2013) . CAE presents most often between 4 and 10 years of age, whereas JAE usually starts between 10 and 17 years of age. Furthermore, in CAE absence seizures occur more frequently, whereas the frequency of tonic-clonic seizures and chronic drug dependency is lower compared to JAE (Hughes, 2009; Tenney & Glauser, 2013; Trinka et al., 2004) .
Starting from early descriptions, children with AE have been considered to have a normal cognitive functioning (Adie, 1924; Currier, Kooi, & Saidman, 1963) . In the last two decades, however, numerous studies have reported cognitive weaknesses in children with AE in various cognitive domains such as intelligence, executive functioning, attention, and language (Caplan et al., 2008; Cerminara et al., 2013; Cheng et al., 2017; D'Agati, Cerminara, Casarelli, Pitzianti, & Curatolo, 2012; Kernan et al., 2012; Levav et al., 2002; Masur et al., 2013; Verrotti, Matricardi, Rinaldi, Prezioso, & Coppola, 2015) .
Nevertheless, data on the course of cognitive functioning in children with AE are still scarce as most studies only report cross-sectional data. A longitudinal study on cognitive development in a heterogeneous group of children with epilepsy (CAE n = 2) found that performance IQ was initially lower than verbal IQ; however, this discrepancy decreased over time during the course of the epilepsy (van Iterson, Zijlstra, Augustijn, van der Leij, & de Jong, 2014) . To date, only two studies investigated cognitive performance in AE over time. Both studies used a limited follow-up period between 10 and 12 months. Siren et al. measured cognitive performance before and 10 months after the introduction of medication in a small sample (n = 6-10) of children with AE (Siren et al., 2007) . No significant change was found in verbal-IQ, performance-IQ, auditory/visual reaction times, and spatial memory. Significant improvements were noted in visual memory, fine-motor fluency, and attention; however, the control group did also improve in fine-motor fluency and attention. Furthermore, the authors speculated that the lack of improvement in verbal-IQ compared to the improvement observed in the control group may indicate an attenuation of the practice or maturation effect. The second study a large randomized clinical trial reported attentional deficits in one-third of drug-naïve patients at the time of diagnosis. These attentional deficits persisted after 1-year follow-up despite successful treatment or the randomly allocated treatment (Cnaan et al., 2017; Glauser et al., 2013 Glauser et al., , 2010 Masur et al., 2013) . Based on behavioral questionnaires from the same trial, attentional problems seem to improve during 1 year of follow-up (Shinnar et al., 2017) . Nevertheless, follow-up data within other cognitive domains were not available. We hypothesized that cognitive deficits in children with AE would show an improvement over time during adequate treatment.
Additional data on neurocognitive development and follow-up in children with AE are needed, especially since the benign nature of this syndrome has been questioned (Caplan et al., 2008) . Persistence of cognitive weaknesses may hamper normal neurocognitive development, potentially leading to problems later in life. Moreover, only limited data on neurocognitive development in AE are currently available and are either based on the average change in test scores or a change in the prevalence of cognitive deficits in a sample. No data exist on individual changes in cognitive development. This is especially important as average changes do not reflect individual changes per se and individual changes are only reliable if they exceed the measurement error of the test (Iverson, 2012) .
The primary aim of the current study is to report on cognitive development during long term follow up using two consecutive cognitive measurements in children with AE. This is done by retrospectively analyzing cognitive development on a group level and on an individual level.
Methods

Inclusion
Children with a clinical diagnosis of AE referred between 2010 and 2017 to Kempenhaeghe Epilepsy Center, a tertiary epilepsy center, were included based on the following criteria: (1) Patients with absences seizures with an onset between 2 and 18 years of age and an EEG showing ictal 3 Hz (2.5-4.5 Hz) generalized rhythmic (poly)spike-and-wave complexes or in adolescence faster irregular 3.5-6 Hz generalized spike-and-wave and polyspike-andwaves (a diagnosis according to ILAE statements for CAE and JAE) (Berg et al., 2010; Fisher et al., 2017; Scheffer et al., 2017, p. 2) A clinical follow-up duration of at least 1 year with a minimum of two neuropsychological assessments. It was not a requirement for the patient to be drug-naïve at the first assessment. All included children and/or parents had given permission for the use of medical charts for research purposes. This research protocol was approved by the local medical ethics committee.
Clinical, neuropsychological, and educational achievement assessment
All children underwent at least two multidisciplinary assessments as part of regular clinical care, which included a medical assessment, an ambulatory 24h-EEG, a neuropsychological/ behavioral assessment, and an academic assessment. A description of the neuropsychological and educational-achievement tests used is presented in Table 1 . Neuropsychological tests were classified to cognitive domains using Baron's distinction of different neurocognitive domains in child neuropsychology (Baron, 2004) . The following neurocognitive domains were systematically assessed: intelligence, attention, visual-perceptual function, language, and memory/learning.
All medical charts were carefully inspected and clinical data such as the age of onset, semiology, drug-history (24 h)-(video)-EEG findings, and school performances were collected in an online data management system (Castor Electronic Data Capture, CIWIT bv, The Netherlands). EEG reports were all scored by a clinical neurophysiologist. Presence of school and behavioral problems were derived from reports of a neuropsychologist and academic evaluations by a school-specialist and defined according to Massa et al. (Table 2) (Massa et al., 2001) . Educational underachievement was defined as: absent; mild, reported by teachers but allowing normal schooling; moderate, requiring individualized help (1-year delay); severe, requiring special educational measures (≥2-year delay). Behavioral problems were defined as: absent; mild, reported by parents but causing minor harm to others; moderate, requiring (Kort et al., 2005; Wechsler, 1992) An intelligence test for children aged 6-17 years, consisting of 13 subtests. Intellectual ability in this study was expressed in full-scale IQ, verbal IQ, performance IQ, perceptual organization index, verbal comprehension index, and processing speed index.
Attention
Bourdon-Vos (Vos, 1988) A cancelation test requiring sustained attention and vigilance for visual stimuli, for children aged 6-17 years. The test consists of a page with 33 lines with 24 dotted characters, in which a specific figure (target stimulus) has to be crossed out as quickly and accurate as possible.
Iron Psyche (FePsy 2.0) (Alpherts & Aldenkamp, 1995) (1) Auditory/visual reaction time (2) Binary choice task Computerized neuropsychological battery for children from ± 7 years of age.
(1) Reaction times for simple auditory or visual stimuli are measured.
(2) The binary choice task consists of 60 visual stimuli, in which a colored dot appears and the button on the same side (left or right) has to be pressed.
(3) CVST A visual searching task, measuring visual (complex) information processing and perceptualmental strategies. It consists of 24 screens of 24 checkerboards, in which the identical figure to the one in the middle has to be found as quickly as possible. Adapted from Goldstein's visual searching task.
Visual-perceptual function Beery-VMI (Beery & Beery, 2006) Visual-motor integration tests, for children from 2 years of age. It consists of a developmental sequence of 27 geometric forms to be copied with paper and pencil.
Language PPVT-III-NL (Dunn & Dunn, 1997) A receptive vocabulary and verbal ability test in children from 2 to 3 years old. The test is administered verbally and no reading is required. It consists of pages with four pictures of which the picture corresponding to the spoken word by the examiner has to be identified.
Memory and learning R-AVLT (Kalverboer & Deelman, 1986 ) Rey auditory verbal learning task: An auditory-verbal memory test, for children from 6 years of age, consisting of 5 rounds of immediate recall of 15 spoken words. After 20 min, it is followed by a round of delayed recall.
Educational achievement
Speeded reading test (De Vos, 2000 , De Vos, 2002 Word and sentence reading speed. The outcome is measured in months ahead or behind compared to the current amount of months of teaching instruction in school.
Speeded arithmetic test (De Vos, 2004) Arithmetic speed. The outcome is measured in months ahead or behind compared to the current amount of months of teaching instruction in school.
Abbreviations psychotherapeutic or pharmacologic interventions; severe, provoking major difficulties despite adequate management.
Statistical analysis
Neurocognitive development on a group level Mean scores for each neurocognitive test were compared to the normative mean using a one-sample t-test. The mean difference between the two measurements was calculated as an absolute difference and calculated as the difference per year to account for differences in follow-up time and tested using a one-sample t-test. A p value of .05 was considered to indicate statistical significance.
Neurocognitive development per individual
Average changes in neurocognitive domains on a group level do not equal the amount of significant change in neurocognitive performance on an individual level per se. Different methods have been described to assess individual change, such as the reliable change methodology and regression-based methods (Iverson, Lovell, & Collins, 2003) . A widely adopted method is the reliable change index (RCI) methodology, initially described by Jacobson & Truax (1991) , which is preferred over regression-based methods for assessing reliable change in studies without a large sample size (Iverson et al., 2003) . The RCI determines whether a change in function exceeds the probable range of measurement error (Iverson, 2012) . The RCI requires a calculation of the standard error of the difference (SEdiff). Subsequently, the amount of change in test scores is divided by the SEdiff. Therefore, the magnitude of change is expressed relative to the SEdiff. If the RCI exceeds the critical value (for example, ±1.64 or ±1.94) it is considered a reliable change. With this method the probability (area under the curve) of the change happening due to chance can be calculated. This would not be possible by calculating cut-off values for reliable change for each test (by multiplying the SEdiff of the test by the critical value). This is important as the use of multiple tests increases the likelihood of finding reliable changes due to chance (Iverson et al., 2003) . For this study, we considered a critical value of ±1.64 (90%CI) as a reliable change, as used by Brooks, Holdnack, & Iverson (2016) . Based on this critical value~5% of reliably improved and~5% of reliably declined scores is expected in a nonclinical population. An important factor to take into account when calculating reliable change is the presence of practice effects with serial neurocognitive assessments. The interval between measurements in this study of at least 1 year or more reduces the magnitude of practice effects, although a residual practice effect cannot be entirely discarded. Therefore, the RCI calculations were corrected for the average change in test scores between the first and second measurements as has been used by others (Brooks et al., 2016; Chelune, Naugle, Lüders, Sedlak, & Awad, 1993; Iverson, 2012) . However, this method does not account for the range of practice effects, as some may improve and others may worsen (Iverson et al., 2003) . It has been proposed that correction for practice effects is only required if at least ≥ 75% of the sample shows an improvement, but this cut-off may still be arbitrary (Iverson, 2001 ). Instead, we did not correct for practice effects if the overall difference in cognitive mean scores was negative. In some instances, we opted to report RCIs with and without correction for practice effects. Most studies on test-retest scores have been performed in healthy subjects over a relatively short period of time (2-6 weeks). Little is known on test-retest results over a long period of time in healthy subjects and whether this resembles test-retest scores in clinical samples. Therefore, we preferably used reliability coefficients based on internal consistency (e.g., Cronbach's alpha), rather than test-retest coefficients. Although no consensus exists on this matter, the use of internal consistency has been recommended for clinical samples (Martinovich, Saunders, & Howard, 1996; Tingey, Lambert, Burlingame, & Hansen, 1996) . If available, reliability coefficients corresponding to a specific age group were used (as these constitute large tables, we refer to the test manuals for reference). Furthermore, when calculating the RCI, the normative SD was used, as the difference was based on standardized scores (corrected for age). For each measurement, a standard error of measurement was calculated by multiplying the standard deviation with the square root of minus 1 the reliability coefficient.
Formulas used to calculate the reliable change index
Abbreviations: SD, normative standard deviation of the test; r1, correlation coefficient (internal consistency or test-retest coefficient) for the 1 st measurement derived from test manuals; r2, correlation coefficient (internal consistency or test-retest coefficient) for the second measurement derived from test manuals; RCI, reliable change index; x ̅ 1, sample mean at first measurement; x ̅ 2, sample mean at the second measurement.
Explorative correlations with cognitive development Bivariate correlations with the average change in test scores were computed for the following clinical parameters: age of onset; total duration of epilepsy; seizure freedom at second neurocognitive assessment; the difference in drug-load between measurements. The following EEG parameters were considered: the longest observed duration of generalized spike-and-wave discharges recorded by EEG in seconds (longest GSW discharge); presence of a focal onset with rapid generalization in one or more of the generalized discharges (defined as 1 s of focal discharge before generalization) (focal onset); presence of ictal and/or inter-ictal polyspikes; the index per hour of generalized spike-and-wave discharges (≥3 s) counted in 2 random hours and the first hour after awakening (seizure frequency). For normally distributed data the Pearson's chi-square test for correlation was used and for not normally distributed data the Spearman rank test was used. A p value of .05 was considered to indicate statistical significance. All analyses were performed using SPSS (version 23, IBM, USA).
Results
Population
Clinical characteristics of the included children are presented in Table 2 . Twenty-seven children were classified as CAE and four children as JAE, based on clinical presentation and EEG criteria. In total, 31 children (from a sample of 55 children) met the inclusion criteria, with a mean age of onset of 6.6 ± 2.2 years and a mean follow-up of 3.7 ± 1.6 years. Six children had generalized discharges of more than 20 s in their EEG, but not longer than 30 s. Eleven children had a focal onset, mostly frontal with rapid generalization. Ten had polyspikes of which nine had generalized ictal polyspike-and-wave complexes and seven had interictal polyspikes. In six children polytherapy was needed. At the time of the first measurement, only two children were seizure free. At the second measurement 10 children were seizure free while performing the WISC-III, six while performing the Bourdon-Vos, nine while performing the Fepsy, eight while performing the PPVT-III, and 10 while performing the Beery-VMI. At the time of data gathering (Feb 2018) 23 children were seizure free of which 10 were without antiepileptic drugs (AED).
Cognitive comorbidities and academic development
At the beginning of the follow-up in our center one patient was already diagnosed with attention deficit hyperactivity disorder AD(H)D. During follow-up, additional six children were diagnosed with AD(H)D, one with autism spectrum disorder, one with developmental coordination disorder (DCD), eight with dyslexia, and one with dyscalculia. Furthermore, during follow-up, one patient had endured an absence status epilepticus and another patient with JAE developed generalized tonic-clonic seizures.
Using the scoring system by Massa et al., 20 (65%) children had mild-to-severe educational underachievement and seven (23%) children had mild-to-severe behavioral problems (Massa et al., 2001) .
Neurocognitive performance at the first and second measurements
Results on neurocognitive performance for both measurements are shown in Table 3 . Mean intelligence scores (WISC-III) were within the normal clinical range (mean = 94.33). Performance IQ and perceptual organization index were significantly lower compared to a normative value of 100 for both measurements. Full-scale IQ, verbal IQ, and verbal comprehension index were not significantly different from a normative value of 100. Furthermore, processing speed was not significantly lower at the first measurement but was significantly lower at the second measurement. Sustained visual attention (Bourdon-Vos cancelation task) was significantly lower compared to the normative mean for speed at the first measurement, whereas accuracy did not differ significantly. The average z-score for speed and accuracy (combination score) was significantly lower for the first measurement, but not the second measurement. Both auditory and visual simple reaction times (FEPSY) of the dominant hand were significantly lower than the normative meanscore. More complex attention processes like the binary choice reaction or computerized visual searching task did not differ Intelligence Scale for Children *p < 0.05; † Z-score; § standard score; ¶ A combination score for sustained attention was calculated by averaging the z-scores for speed and accuracy.
significantly compared to the norm. Visual motor integration was significantly lower compared to the normative mean. The average scores of the Peabody Picture Vocabulary Test (receptive vocabulary) and the Rey-Auditory Verbal Learning Test (immediate and delayed recall for verbal memory) did not differ significantly compared to the norm for both measurements. Speeded reading and arithmetic performance were not significantly delayed at both measurements.
Neurocognitive development on a group level
Results on the average difference per year between both measurements are shown in Table 3 . On average the first and second neuropsychological assessments were 1.7 ± 0.95 years apart. Sustained attention (combination score) improved significantly between the first and second measurements (Table 3) . Receptive vocabulary declined significantly between the first and second measurements, but on average was still within the normal clinical range. Other neurocognitive results (standardized for age) did not differ significantly between the first and second measurements. Excluding the four patients with JAE from the analysis did not yield different results. Table 4 shows the reliable change scores per individual as well as the number of reliably changed children per test. In most tests, the majority of children did not undergo a reliable change, except for sustained attention, simple reaction times, and the computerized visual searching task. Sustained attention (combination score) showed the highest frequency of reliable change, with an improvement in 7 out of 14 children after correction for practice effects. As the average difference in improvement between measurements in sustained attention scores was a reliable improvement by itself, correcting for this effect in children who performed normal on both tests, would wrongly designate these children as reliably worsened. Therefore, corrected RCIs are only shown for those children who showed an improvement in Table 4 , as well as, the uncorrected RCIs for all children. Two children with JAE showed a reliable decline in sustained attention, while another child with JAE showed a reliable improvement in sustained attention. Auditory reaction times improved in five and worsened in 6 out of 19. Visual reaction times improved in four and worsened in 5 out of 18. Performance in the computerized visual searching task improved in three and worsened in two out of nine. Receptive vocabulary worsened in 4 out of 11.
Neurocognitive development on an individual level (reliable change index)
Explorative correlations of clinical and baseline EEG parameters with cognitive function
Explorative correlations are presented in Table 5 . Performance IQ, processing speed, sustained attention, and receptive vocabulary were considered for explorative correlations as these showed the largest differences between measurements 1 and 2 on a group level. Baseline EEG-parameters did not correlate significantly with the difference between cognitive measurements for seizure frequency, longest generalized spike- 
The reliable change index (RCI) and/or the RCI-corrected for practice effects is presented (RCI-C). The color green represents a reliable improvement and the color red represents a reliable decline at a critical value of ±1.64 (p < .1, two-sided).
* Scores <-1SD at measurement 1 and/or 2 ** Improvement from <-1SD to >-1SD ¶ Scores omitted as the corrected RCI would yield spurious results in those children who did not improve/had stable scores. Abbreviations: BCR, binary choice reaction; CVST, computerized visual searching task; Diff., difference; Fepsy, a neuropsychological computerized test battery; IQ, intelligence quotient; NA, not available; POI, perceptual organization index; PPVT, Peabody Picture Vocabulary Test; PT, patient; RCI, reliable change index; RCI-C, reliable change indexcorrected; RT-A, auditory reaction time; RT-V, visual reaction time; VCI, verbal comprehension index; VMI, visual motor integration; WISC, Wechsler Intelligence Scale for Children. wave complex, the presence of polyspikes, or a focal onset. Clinical parameters did not correlate significantly with the difference between cognitive measurements for the age of onset, the total duration of epilepsy or seizure freedom at the time of the second neurocognitive assessment. The difference in drug load between measurements did correlate positively with the difference in sustained attention scores. However, on closer inspection, this correlation was based on three patients who were taking less AEDs during the second measurement, but the specific change in AED regimes was different for all these patients (see Table 2 , patients 4, 11, 20).
Discussion
Our aim was to assess cognitive development in children with AE over time, as data on the course of cognitive performance in children with AE is scarce. These data demonstrate that children with AE improve in sustained attention over time, as reflected by significant improvement as a group and a reliable improvement in up to half of the patients. Receptive vocabulary showed a decline over time, but cognitive performance was still within normal clinical range. In line with previous cross-sectional research (Conant, Wilfong, Inglese, & Schwarte, 2010; D'Agati et al., 2012; Masur et al., 2013) , lower than average scores for performance-IQ, perceptual organization, processing speed, attention, simple reaction times, and visual motor integration were found, which in this study were shown to persist over time, despite some children improving or worsening in specific cognitive domains. Furthermore, although cognitive scores were statistically lower compared to normative data, average scores still fall well within the average clinical range and are only clinically relevant in some. Furthermore, a high frequency of mild-to-severe academic difficulties and comorbidities that might affect learning were present. Attentional weaknesses in children with AE have been reported in the past; however, uncertainty exists whether this reflects a momentary observation or whether attention improves over time. We observed a substantial improvement in the performance of sustained attention during long-term follow-up in about half of the children. Although an improvement of sustained attention in the study of Siren et al. was seen over a 10-month period, this was also seen in the control group. However, as their study did not use age-corrected norms, the observed improvement in both groups may be attributable to an age effect as the authors stated. Baseline data of a large randomized clinical trial (RCT) found attentional deficits were present in up to one-third of patients with CAE and were directly related to performance in memory, executive function, and achievement tests . On the contrary, improvement in sustained attention in this study did not coincide with similar improvement in other cognitive domains. Furthermore, although attentional deficits in this RCT were associated with the use of Valproate, the overall prevalence of attentional deficits from baseline up to 12 months of follow-up remained roughly the same, while some improved and some worsened (Cnaan et al., 2017; Glauser et al., 2013; Masur et al., 2013) . However, in line with our results, modest improvements in attention were reported in a by proxy questionnaire in the same RCT after 1 year (Shinnar et al., 2017) . Based on the data in our study with a longer follow-up time, it seems that an improvement in attention becomes apparent after a follow-up time of more than 12 months and occurs in both children with and without seizure freedom.
In this study, some children experienced a worsening in cognitive function in specific cognitive domains, especially in receptive vocabulary and auditory-verbal delayed recall. Performance-IQ and reaction times also had a relatively high frequency of decline, although the frequency of improvement was similar. Despite a decline in receptive vocabulary in some, performance was within normal clinical range in most children. Receptive vocabulary (PPVT-III) in the study by Masur et al. was also normal in recently diagnosed drug-naïve children with CAE compared to the normative mean , while Jackson et al. reported a lower performance in receptive vocabulary in children with AE at 8-month follow-up compared to controls (Jackson et al., 2018) . Although in the latter study, verbal-IQ was also significantly lower than controls, which is in contrast with our study.
Persistence of lower than average performance during follow-up in our study is in line with the sparse literature on cognitive functioning in adults who suffered from AE during their childhood. A small study by Hommet et al. in adults with CAE in remission reported a full-scale IQ of 92 (69-99), a performance IQ of 85 (66-117), with particularly low scores in the picture arrangement, block design, and object assembly subtests of the WAIS-R (Hommet et al., 2001 ). Language and executive functioning, however, did not differ with a control group. Recently, Loughman et al. reported lower scores on brief intellectual ability, crystallized intelligence, new learning/ memory, and speed of processing in an adult population of genetic generalized epilepsy comprising of CAE and JAE patients (Loughman, Bowden, & D'Souza, 2017) . Abarrategui et al. reported lower scores in visual-spatial working memory, processing speed (coding), cognitive flexibility, abstract visual spatial, verbal reasoning, and acquired knowledge in patients with CAE and JAE persisting into adulthood. The persistence of other cognitive weaknesses even after cessation of seizures, in combination with the emerging evidence of cognitive weaknesses in adults with a history of AE, is in contrast with the allegedly benign nature of the syndrome. Moreover, in line with previous research, the presence of mild-to-severe academic difficulties in 65% and related comorbidities in 42% in this study is high and adds to the clinical relevance (Berg, Levy, Testa, & Blumenfeld, 2014; Caplan et al., 2008; Covanis, Skiadas, Loli, Lada, & Theodorou, 1992; Oostrom et al., 2003; Urena-Hornos et al., 2004) . Therefore, it is recommended that children with AE are monitored for cognitive deficits and educational underachievement. Long-term prospective cohort studies with repeated measures on cognition and educational achievement are warranted.
Cognitive development was not associated with seizure freedom, the duration of epilepsy or EEG variables and may suggest that underlying mechanisms other than the ictal activity per se are responsible for the association between cognitive weaknesses and absence epilepsy. Siren et al. concluded that the improvements in cognition were due to attaining seizure freedom. However, as the majority (10 out of 11) were seizure free, a direct relationship was difficult to test in that study (Siren et al., 2007) . Furthermore, drug-load was not correlated with neurocognitive development in this study and correlations with specific AED use were not possible due to insufficient power. Nevertheless, AED treatment may have had an impact on neurocognitive performance and development. Ethosuximide has been associated with lower performance on simple reaction times but does not seem to affect measures on intelligence, processing speed, sustained attention with the Bourdon-Vos, visual motor integration, or verbal memory (IJff et al., 2016) . Valproate has been associated with additional numbers of attentional deficits on the continuous performance task compared to monotherapy with Ethosuximide or Lamotrigine (Cnaan et al., 2017; Glauser et al., 2013 Glauser et al., , 2010 . In this study, some children showed an improvement in sustained attention despite the use of Valproic acid. A previous systematic review concluded that Lamotrigine is not associated with reduced cognitive function (Aldenkamp & Baker, 2001 ), but may increase attentional performance slightly. In this study, a reliable improvement in sustained attention was noted in all children in who Lamotrigine was added after the first measurement. It should be noted that the use of various AEDs may have had a bearing on our results.
This study was performed in a tertiary epilepsy center, in which the AE patients were closely monitored regarding clinical, cognitive, and EEG aspects during follow-up. Importantly, a large proportion of the AE patients were difficult to treat in this population; however, previously it has been shown that about half of CAE patients fail treatment on the first and second monotherapies (Cnaan et al., 2017; Glauser et al., 2013 Glauser et al., , 2010 Tenney & Glauser, 2013) . Furthermore, as this study focused on cognitive development, only children with two neuropsychological assessments were included. Due to the retrospective setup, the time points of the cognitive assessments and total follow-up time varies between patients. Lack of significant correlations may be related to the relatively small sample size in this study. This was taken into account by correcting for the time between cognitive assessments and using age-corrected norms.
Conclusion
This study in children with AE demonstrates that weaknesses in sustained attention improved during long-term follow-up. Despite some children showing an improvement or worsening in specific cognitive domains, cognitive functioning, in general, was stable over time. Nevertheless, average functioning in performance-IQ, perceptual organization index, processing speed, simple reaction times, and visual-motor-integration was lower compared to normative values, although still within normal clinical range, while cognitive weaknesses were only present in a proportion of the children. Receptive vocabulary did show a decline over time, but cognitive performance was within normal clinical range. Seizure freedom was not correlated with any aspect of cognitive development as assessed in this study. Furthermore, a high prevalence of mild-to-severe academic difficulties and additional comorbidities that might affect learning was present in our sample.
